16-15643570-C-CT
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_001143979.2(NDE1):c.-512dupT variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0187 in 260,198 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00086 ( 0 hom., cov: 31)
Exomes 𝑓: 0.042 ( 0 hom. )
Consequence
NDE1
NM_001143979.2 5_prime_UTR
NM_001143979.2 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.176
Genes affected
NDE1 (HGNC:17619): (nudE neurodevelopment protein 1) This gene encodes a member of the nuclear distribution E (NudE) family of proteins. The encoded protein is localized at the centrosome and interacts with other centrosome components as part of a multiprotein complex that regulates dynein function. This protein plays an essential role in microtubule organization, mitosis and neuronal migration. Mutations in this gene cause lissencephaly 4, a disorder characterized by lissencephaly, severe brain atrophy, microcephaly, and severe cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012]
MIR484 (HGNC:32341): (microRNA 484) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
PM2
Variant has high frequency in the NFE (0.0424) population. However there is too low homozygotes in high coverage region: (expected more than 22, got 0).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00086 (126/146476) while in subpopulation AMR AF = 0.00136 (20/14664). AF 95% confidence interval is 0.000903. There are 0 homozygotes in GnomAd4. There are 61 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position FAILED quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDE1 | NM_001143979.2 | c.-512dupT | 5_prime_UTR_variant | Exon 1 of 10 | NP_001137451.1 | |||
NDE1 | XM_006720897.5 | c.-294dupT | 5_prime_UTR_variant | Exon 1 of 8 | XP_006720960.1 | |||
NDE1 | XM_047434258.1 | c.-294dupT | 5_prime_UTR_variant | Exon 1 of 8 | XP_047290214.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDE1 | ENST00000396355 | c.-512dupT | 5_prime_UTR_variant | Exon 1 of 10 | 1 | ENSP00000379643.1 | ||||
NDE1 | ENST00000674888.1 | n.-401_-400insT | upstream_gene_variant | ENSP00000501936.1 | ||||||
MIR484 | ENST00000606601.3 | n.*198_*199insT | downstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.000854 AC: 125AN: 146424Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
125
AN:
146424
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0418 AC: 4752AN: 113722Hom.: 0 Cov.: 0 AF XY: 0.0409 AC XY: 2686AN XY: 65746 show subpopulations
GnomAD4 exome
AF:
AC:
4752
AN:
113722
Hom.:
Cov.:
0
AF XY:
AC XY:
2686
AN XY:
65746
Gnomad4 AFR exome
AF:
AC:
28
AN:
728
Gnomad4 AMR exome
AF:
AC:
54
AN:
1632
Gnomad4 ASJ exome
AF:
AC:
129
AN:
3342
Gnomad4 EAS exome
AF:
AC:
34
AN:
786
Gnomad4 SAS exome
AF:
AC:
1009
AN:
25320
Gnomad4 FIN exome
AF:
AC:
261
AN:
7946
Gnomad4 NFE exome
AF:
AC:
2966
AN:
67846
Gnomad4 Remaining exome
AF:
AC:
243
AN:
5358
⚠️ The allele balance in gnomAD4 Exomes is highly skewed (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Heterozygous variant carriers
0
614
1228
1843
2457
3071
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000860 AC: 126AN: 146476Hom.: 0 Cov.: 31 AF XY: 0.000857 AC XY: 61AN XY: 71208 show subpopulations
GnomAD4 genome
AF:
AC:
126
AN:
146476
Hom.:
Cov.:
31
AF XY:
AC XY:
61
AN XY:
71208
Gnomad4 AFR
AF:
AC:
0.00094598
AN:
0.00094598
Gnomad4 AMR
AF:
AC:
0.00136388
AN:
0.00136388
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0.00059453
AN:
0.00059453
Gnomad4 SAS
AF:
AC:
0.00107666
AN:
0.00107666
Gnomad4 FIN
AF:
AC:
0.000768218
AN:
0.000768218
Gnomad4 NFE
AF:
AC:
0.000769602
AN:
0.000769602
Gnomad4 OTH
AF:
AC:
0.000995025
AN:
0.000995025
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Lissencephaly, Recessive Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=300/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at